https://www.selleckchem.com/pr....oducts/Glycyrrhizic-
The clinical trials validating these markers have been promising but have yet to show a clear benefit in brain tumors. This identification of alternative methods to address these markers or identify additional targets may be the key to the fight against this disease. The molecular targeting of glioblastoma pathways may have significant impact on disease control and patient survival.The aim of this narrative review was to provide an update on the use of sentinel lymph node biopsy (SLN for breast carcinoma (BC). Relevant studi